First copies of gilead virus drug to start selling in Bangladesh
2301 Thursday, 21 May, 2020, 15:45 Bangladesh’s Beximco Pharmaceuticals Ltd. said it has become the world’s first company to start selling the generic version of Gilead Sciences Inc.’s antiviral drug on mounting urgency to treat the infection caused by the deadly coronavirus across the developing world. The Dhaka-based Beximco, which counts Norges Bank as one of its investors, will sell remdesivir for about 6,000 taka ($71) a vial to private clinics but will give it free to state-run hospitals treating Covid-19 patients, Rabbur Reza, chief operating officer at the company, said in an interview. A critically ill Covid-19 patient will need at least six vials, he said. |
Pig kidney transplanted into living person for first time (photo)
153221.03.2024, 20:48First person dies from Alaskapox virus
609412.02.2024, 18:06Record-breaking doctors' strike piles pressure on England's health service
1186203.01.2024, 19:30China Hospitals overwhelmed with children suffering pneumonia
1418023.11.2023, 10:18WHO Concerned by Report of Israeli Evacuation Warning to Gaza Al-Quds Hospital
893929.10.2023, 19:00Pakistan police bust organ trafficking ring that took kidneys from hundreds
1618920.10.2023, 23:42Israel-Hamas war live: Gaza humanitarian crisis deepens amid calls for aid
1600117.10.2023, 00:30Gaza: Nowhere to go, as humanitarian crisis reaches 'dangerous new low'
1542513.10.2023, 23:48